Ventilator-associated pneumonia rates in critical care units in 3 Arabian Gulf countries: A 6-year surveillance study
| Autor: | Ayman El Gammal, Seif S. Al-Abri, Hanan H. Balkhy, Abdulhakeem O. Althaqafi, Wafa Al Nasser, Zaina Al Maskari, Jameela Alsalman, Amina Al-Jardani, Huda Alansari, Aiman El-Saed |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Surveillance study Critical Care Oman Epidemiology 030106 microbiology Saudi Arabia 03 medical and health sciences 0302 clinical medicine Intensive care Infection control Medicine Humans 030212 general & internal medicine Intensive care medicine business.industry Health Policy Incidence (epidemiology) Incidence Public Health Environmental and Occupational Health Ventilator-associated pneumonia Pneumonia Ventilator-Associated bacterial infections and mycoses medicine.disease Nosocomial infection control Confidence interval respiratory tract diseases Pneumonia Infectious Diseases Bahrain Epidemiological Monitoring business |
| Zdroj: | American journal of infection control. 44(7) |
| ISSN: | 1527-3296 |
| Popis: | Background Data estimating the rates of ventilator-associated pneumonia (VAP) in critical patients in Gulf Cooperation Council (GCC) countries are very limited. The aim of this study was to estimate VAP rates in GCC hospitals and to compare rates with published reports of the U.S. National Healthcare Safety Network (NHSN) and International Nosocomial Infection Control Consortium (INICC). Methods VAP rates and ventilator utilization between 2008 and 2013 were calculated from aggregate VAP surveillance data using NHSN methodology pooled from 6 hospitals in 3 GCC countries: Saudi Arabia, Oman, and Bahrain. The standardized infection ratios of VAP in GCC hospitals were compared with published reports of the NHSN and INICC. Results A total of 368 VAP events were diagnosed during a 6-year period covering 76,749 ventilator days and 134,994 patient days. The overall VAP rate was 4.8 per 1,000 ventilator days (95% confidence interval, 4.3-5.3), with an overall ventilator utilization of 0.57. The VAP rates showed a wide variability between different types of intensive care units (ICUs) and were decreasing over time. After adjusting for the differences in ICU type, the risk of VAP in GCC hospitals was 217% higher than NHSN hospitals and 69% lower than INICC hospitals. Conclusions The risk of VAP in ICU patients in GCC countries is higher than pooled U.S. VAP rates but lower than pooled rates from developing countries participating in the INICC. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect